View source for Ihor Hayduchok

<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Ihor Hayduchok|English]] · [[Ihor Hayduchok/uk|Українська]] · [[Ihor Hayduchok/es|Español]] · [[Ihor Hayduchok/fr|Français]] · [[Ihor Hayduchok/de|Deutsch]] · [[Ihor Hayduchok/pt|Português]]</div>
'''Ihor Hayduchok''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography.

== Documented work ==
Coauthor of a 2021 paper on addiction pharmacotherapy risks and illicit psychoactive-substance circulation during the pandemic.

'''Research context:''' Forensic-pharmaceutical analysis and legislative proposals, rather than a controlled treatment trial.

'''Named collaborators on this work:''' [[Valerii Shapovalov]].

* [https://doi.org/10.53933/sspmpm.v1i2.32 DOI 10.53933/sspmpm.v1i2.32]
* [https://archive.sreif.us/index.php/mpm/article/view/32 Publisher record / source text]

== Identity and evidence notes ==
The cited 2021 page links ORCID 0000-0003-2897-8417. Later similarly named records have been associated with a different ORCID; this entry does not merge those identities or assert the later record belongs to this author without reconciliation.

Inclusion records authorship of the cited work, not endorsement of every later [[Vision 2035]] proposal. Publication affiliations are historical unless separately updated.

See [[People and attribution]] and [[Research network]].
[[Category:People]]